Adverse events associated with prescription drug cost-sharing among poor and elderly persons R Tamblyn, R Laprise, JA Hanley, M Abrahamowicz, S Scott, N Mayo, ... Jama 285 (4), 421-429, 2001 | 1151 | 2001 |
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of … AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ... Canadian Journal of Cardiology 32 (5), 569-588, 2016 | 548 | 2016 |
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ... Canadian Journal of Cardiology 31 (5), 549-568, 2015 | 491 | 2015 |
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ... Canadian Journal of Cardiology 30 (5), 485-501, 2014 | 376 | 2014 |
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy NA Khan, B Hemmelgarn, RJ Herman, CM Bell, JL Mahon, LA Leiter, ... Canadian Journal of Cardiology 25 (5), 287-298, 2009 | 341 | 2009 |
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. EL Schiffrin, LY Deng, P Larochelle Hypertension 23 (1), 83-91, 1994 | 339 | 1994 |
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ... Canadian Journal of Cardiology 26 (5), 249-258, 2010 | 318 | 2010 |
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ... Canadian Journal of Cardiology 29 (5), 528-542, 2013 | 306 | 2013 |
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II–therapy NA Khan, FA McAlister, SW Rabkin, R Padwal, RD Feldman, ... Canadian Journal of Cardiology 22 (7), 583-593, 2006 | 279 | 2006 |
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy SS Daskalopoulou, NA Khan, RR Quinn, M Ruzicka, DW McKay, ... Canadian Journal of Cardiology 28 (3), 270-287, 2012 | 275 | 2012 |
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study A Zanchetti, L Hansson, B Dahlöf, D Elmfeldt, S Kjeldsen, R Kolloch, ... Journal of hypertension 19 (6), 1149-1159, 2001 | 258 | 2001 |
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial SE Kjeldsen, S Julius, G Mancia, GT McInnes, T Hua, MA Weber, A Coca, ... Journal of hypertension 24 (7), 1405-1412, 2006 | 251 | 2006 |
1999 Canadian recommendations for the management of hypertension RD Feldman, N Campbell, P Larochelle, P Bolli, ED Burgess, ... Cmaj 161 (12 suppl), S1-S17, 1999 | 235 | 1999 |
Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor … EL Schiffrin, LY Deng, P Larochelle American journal of hypertension 8 (3), 229-236, 1995 | 178 | 1995 |
Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians Z Pausova, B Deslauriers, D Gaudet, J Tremblay, TA Kotchen, ... Hypertension 36 (1), 14-19, 2000 | 172 | 2000 |
Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients J de Champlain, M Karas, P Nguyen, P Cartier, R Wistaff, CB Toal, ... Journal of hypertension 16 (9), 1357-1369, 1998 | 159 | 1998 |
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy DM Rabi, SS Daskalopoulou, RS Padwal, NA Khan, SA Grover, ... Canadian Journal of Cardiology 27 (4), 415-433. e2, 2011 | 158 | 2011 |
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. FH Leenen, TW Wilson, P Bolli, P Larochelle, M Myers, SP Handa, ... The Canadian journal of cardiology 13 (10), 914-920, 1997 | 146 | 1997 |
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy NA Khan, B Hemmelgarn, RJ Herman, SW Rabkin, FA McAlister, CM Bell, ... Canadian Journal of Cardiology 24 (6), 465-475, 2008 | 140 | 2008 |
Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients EL Schiffrin, LY Deng, P Larochelle Journal of hypertension 10 (5), 437-444, 1992 | 137 | 1992 |